C3 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-C3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | C3 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.06 mL, 0.12 mL, 0.2 mL |
| Concentration | 1 mg/mL |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. |
| Immunogen | Immunogen: Recombinant protein of human C3 |
| Other Names | [Acylation-stimulating protein cleavage product; AHUS5; ARMD9; ASP; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1; C3; CO3; Complement C3; Complement C3 beta chain; Complement C3c alpha' chain fragment 2; Complement component 3; Complement component C3; Complement factor 3; CPAMD1; Plp] |
| Gene, Accession # | [C3], Gene ID: 718, NCBI: NP_000055.2, UniProt: P01024 |
| Catalog # | MBS2554906 |
| Price | $150, $225, $360 |
| Order / More Info | C3 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies